| Time | Session |
|---|
|
12:00
13:00
|
The Possibility of Using Lenvatinib-based Therapy in Borderline Resectable/ Unresectable HCC Patients
Dr. Hsueh Kuan Chun
Speaker
Tung's Metro Harbor Hospital
|